bibliographicCitation |
Li S, Li W, Jiang W, He L, Peng Q, Wang G, Lu X. The Efficacy of Tocilizumab in the Treatment of Patients with Refractory Immune-Mediated Necrotizing Myopathies: An Open-Label Pilot Study. Front Pharmacol. 2021;12():635654. PMID: 33815117; PMCID: PMC8010666. |